0001437749-20-000169.txt : 20200103
0001437749-20-000169.hdr.sgml : 20200103
20200103164148
ACCESSION NUMBER: 0001437749-20-000169
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191231
FILED AS OF DATE: 20200103
DATE AS OF CHANGE: 20200103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huang James
CENTRAL INDEX KEY: 0001573160
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26422
FILM NUMBER: 20506207
MAIL ADDRESS:
STREET 1: 9620 MEDICAL CENTER DRIVE
STREET 2: SUITE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WINDTREE THERAPEUTICS INC /DE/
CENTRAL INDEX KEY: 0000946486
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171943
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 KELLY ROAD
STREET 2: SUITE 100
CITY: WARRINGTON
STATE: PA
ZIP: 18976
BUSINESS PHONE: 2154889300
MAIL ADDRESS:
STREET 1: 2600 KELLY ROAD
STREET 2: SUITE 100
CITY: WARRINGTON
STATE: PA
ZIP: 18976
FORMER COMPANY:
FORMER CONFORMED NAME: DISCOVERY LABORATORIES INC /DE/
DATE OF NAME CHANGE: 19971201
FORMER COMPANY:
FORMER CONFORMED NAME: ANSAN PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19961121
FORMER COMPANY:
FORMER CONFORMED NAME: ANSAN INC
DATE OF NAME CHANGE: 19950609
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-12-31
0000946486
WINDTREE THERAPEUTICS INC /DE/
WINT
0001573160
Huang James
C/O WINDTREE THERAPEUTICS, INC.
2600 KELLY ROAD, SUITE 100
WARRINGTON
PA
18976
1
1
Common Stock
2019-12-31
4
P
0
15442
4.049
A
20442
D
Common Stock
6182974
I
Via Panacea Venture Healthcare Fund I L.P.
Common Stock
210844
I
Via Rui Jin (HK) Consulting Management Company Limited
The shares were purchased in multiple trades at prices ranging from $3.81 to $4.99. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The Reporting Person is a Director of Panacea Venture Healthcare Fund GP I L.P. The Reporting Person disclaims beneficial ownership of the shares held by Panacea Venture Healthcare Fund I L.P., except to the extent of his pecuniary interest therein.
The Reporting Person is a Director of Rui Jin (HK) Consulting Management Company Limited.
/s/ Mary B. Templeton, Esq., as Attorney-in-Fact
2020-01-03